Low-dose Radiotherapy Combined With Albumin-bound Paclitaxel and AK112 as Second-line Treatment in Patients With Advanced Gastric or Gastroesophageal Junction, G.GEJ Cancer Who Failed First-line Therapy a Single Phase II Trial
Latest Information Update: 30 Jan 2025
Price :
$35 *
At a glance
- Drugs Ivonescimab (Primary) ; Paclitaxel
- Indications Adenocarcinoma; Gastric cancer; Oesophageal cancer
- Focus Adverse reactions; Therapeutic Use
- 30 Jan 2025 New trial record